<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04251286</url>
  </required_header>
  <id_info>
    <org_study_id>NMU-FY2018-54</org_study_id>
    <nct_id>NCT04251286</nct_id>
  </id_info>
  <brief_title>Screening and Follow-up Study of Neonatal Jaundice Based on Mobile Network</brief_title>
  <official_title>Screening and Follow-up Study of Neonatal Jaundice Based on Mobile Network：A Multicentrd, Prospective, Open, Clinical Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nanjing Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Xuzhou Maternity and Child Health Care Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Jiangsu Women and Children Health Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Changzhou Maternity and Child Health Care Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Lianyungang Maternity and Child Health Care Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Affiliated Hospital of Jiangsu University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Suqian First Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Jiangyin People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Nantong Maternity and Child Health Care Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Affiliated Hospital of Xuzhou Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Taizhou People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Yangzhou Maternity and Child Health Care Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Yangzhou University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Nanjing Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      At least 13 hospitals in China will participate in the study, which aims to clarify the
      natural history of jaundice in Chinese healthy newborns，and decrease the incidence of severe
      hyperbilirubinemia and acute bilirubin encephalopathy and even kernicterus. The study is an
      open project, and the investigators welcome institutions fulfilling the specified
      requirements to join the study during the recruitment phase.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective cohort study of healthy term and near-term infants. The mobile network
      screening and follow-up of neonatal jaundice consists of two parts, one is the screening and
      follow-up program for healthy neonatal jaundice by using on parents' mobile phones, the other
      is the online registry of severe hyperbilirubinemia. Firstly，the TCB values of healthy term
      and near-term infants in delivery institutions will be prospectively recorded and followed up
      until jaundice subsided by using screening and follow-up program, so as to clarify the
      natural history of jaundice of healthy newborns in China. Secondly, by establishing an online
      registry for severe hyperbilirubinemia and &quot;Follow up of jaundice&quot; on Wechat applet, the
      investigators will find the specific problems of jaundice management in infants with severe
      hyperbilirubinemia. Lastly, through the follow-up of severe hyperbilirubinemia cases, the
      investigators will have a better understanding of their prognosis.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 1, 2020</start_date>
  <completion_date type="Anticipated">April 30, 2025</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2025</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <target_duration>2 Years</target_duration>
  <primary_outcome>
    <measure>To record the TCB values of Chinese newborns within 28 days after birth.</measure>
    <time_frame>12 months</time_frame>
    <description>Transcutaneous bilirubin (TcB) values will be recorded so as to establish transcutaneous bilirubin nomogram in healthy Chinese term and late-preterm infants at &lt;28 days of age.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The comprehensive prognosis of infants</measure>
    <time_frame>60 months</time_frame>
    <description>To investigate the comprehensive prognosis of infants with severe hyperbilirubinemia at the corrected age of 2 years in a real-world setting in Jiangsu Province.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Risk factors of extreme hyperbilirubinemia</measure>
    <time_frame>36 months</time_frame>
    <description>Extreme hyperbilirubinemia:total serum bilirubin more than 25mg/dL.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The incidence of neurological sequelae.</measure>
    <time_frame>60 months</time_frame>
    <description>To assess the clinical outcome at 2 years of corrected age in cases treated with and without exchange transfusion when TSB is at a level of the threshold</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The completion rate of each jaundice management measure for severe hyperbilirubinemia cases.</measure>
    <time_frame>36 months</time_frame>
    <description>To calculate the completion rate of each jaundice management measure for severe hyperbilirubinemia cases, whose total serum bilirubin are more than 20mg/dL</description>
  </secondary_outcome>
  <enrollment type="Anticipated">4000</enrollment>
  <condition>Hyperbilirubinemia, Neonatal</condition>
  <eligibility>
    <study_pop>
      <textblock>
        For the research on the natural history of jaundice via mobile network, the selected
        population is healthy newborns with gestational age ≥35 weeks and weight ≥2000g, and those
        without phototherapy or hospital intervention. For the study of the online registry for
        severe hyperbilirubinemia, the study population is gestational age ≥35 weeks, weight
        ≥2000g, only hospitalized for jaundice, and the serum total bilirubin reached the threshold
        of exchange transfusion (≤3 days) or the serum total bilirubin ≥20mg / dl (&gt;3 days).
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Term or near-term neonates with gestational age ≥35w and birth weight ≥2000g.

        Exclusion Criteria:

          -  Biliary atresia, serious genetic and metabolic diseases, family history of epilepsy,
             and so on.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>28 Days</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Han Shuping, PHD</last_name>
    <role>Study Director</role>
    <affiliation>Nanjing Maternity and Child Health Care Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yu Zhangbin, PHD</last_name>
    <role>Study Director</role>
    <affiliation>Nanjing Maternity and Child Health Care Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Deng Xiaoyi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Xuzhou Maternity and Child Health Care Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hu Yuhua, PHD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Jiangsu Women and Children Health Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Wang Jinxiu, PHD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Changzhou Maternity and Child Health Care Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Li Qianqian, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Xuzhou Maternity and Child Health Care Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gao Yan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lianyungang Maternity and Child Health Care Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lu Hongyan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Affiliated Hospital of Jiangsu University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Zhang Jia, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Suqian First Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Wan Jun, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Jiangyin People's Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Li Shuangshuang, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nantong Maternity and Child Health Care Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Wu Mingfu, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Yangzhou University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Wu Xinping, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Yangzhou Maternity and Child Health Care Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Wang Jun, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Affiliated Hospital of Xuzhou Medical University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Xue Mei, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Taizhou People's Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Han Shuping, PHD</last_name>
    <phone>+86-025-52226561</phone>
    <email>shupinghan@njmu.edu.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yu Zhangbin, PHD</last_name>
    <phone>+86-025-52226567</phone>
    <email>yuzhangbin@126.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Nanjing Maternity and Child Health Care Hospital</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Han Shuping, PHD</last_name>
      <phone>+86-025-52226561</phone>
      <email>shupinghan@njmu.edu.cn</email>
    </contact>
    <contact_backup>
      <last_name>Yu Zhangbin, PHD</last_name>
      <phone>+86-025-52226567</phone>
      <email>yuzhangbin@126.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>January 16, 2020</study_first_submitted>
  <study_first_submitted_qc>January 30, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 31, 2020</study_first_posted>
  <last_update_submitted>May 21, 2020</last_update_submitted>
  <last_update_submitted_qc>May 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 26, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Nanjing Medical University</investigator_affiliation>
    <investigator_full_name>Zhangbin Yu</investigator_full_name>
    <investigator_title>Principal Investigator of Nan Jing Maternity and Child Health Care Hospital</investigator_title>
  </responsible_party>
  <keyword>Hyperbilirubinemia</keyword>
  <keyword>screening</keyword>
  <keyword>follow-up</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Jaundice, Neonatal</mesh_term>
    <mesh_term>Hyperbilirubinemia, Neonatal</mesh_term>
    <mesh_term>Jaundice</mesh_term>
    <mesh_term>Hyperbilirubinemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>The study is an open project, and the collected data and information will be provided to all participating centers after review by the data management committee. Anyone interested in this research can contact us directly.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_time_frame>The Study Protocol will be shared after the publication until the end of the study.</ipd_time_frame>
    <ipd_access_criteria>All participating centres</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

